Helicobacter pylori and gastrointestinal tract adenocarcinomas. Peek RM, Blaser MJ (2002) Nat Rev Cancer 2: 28-37 Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z (2009) Gastroenterology 137: 588-97 Mucosal impedance discriminates GERD from non-GERD conditions. Ates F, Yuksel ES, Higginbotham T, Slaughter JC, Mabary J, Kavitt RT, Garrett CG, Francis D, Vaezi MF (2015) Gastroenterology 148: 334-43 Proton pump inhibitor therapy improves symptoms in postnasal drainage. Vaezi MF, Hagaman DD, Slaughter JC, Tanner SB, Duncavage JA, Allocco CT, Sparkman C, Clement LE, Wasden CM, Wirth D, Goutte M, McCafferty BA, Lanza DC (2010) Gastroenterology 139: 1887-1893.e1; quiz e11 High economic burden of caring for patients with suspected extraesophageal reflux. Francis DO, Rymer JA, Slaughter JC, Choksi Y, Jiramongkolchai P, Ogbeide E, Tran C, Goutte M, Garrett CG, Hagaman D, Vaezi MF (2013) Am J Gastroenterol 108: 905-11 Symptom reports are not reliable during ambulatory reflux monitoring. Kavitt RT, Higginbotham T, Slaughter JC, Patel D, Yuksel ES, Lominadze Z, Abou-Ismail A, Pasricha T, Garrett CG, Hagaman D, Vaezi MF (2012) Am J Gastroenterol 107: 1826-32 Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM (2002) Am J Gastroenterol 97: 302-11 Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus. Yachimski P, Maqbool S, Bhat YM, Richter JE, Falk GW, Vaezi MF (2015) Am J Gastroenterol 110: 1143-8 Nonlinear relationship between body mass index and esophageal acid exposure in the extraesophageal manifestations of reflux. Aslam M, Slaughter JC, Goutte M, Garrett CG, Hagaman D, Vaezi MF (2012) Clin Gastroenterol Hepatol 10: 874-8 Use of direct, endoscopic-guided measurements of mucosal impedance in diagnosis of gastroesophageal reflux disease. Saritas Yuksel E, Higginbotham T, Slaughter JC, Mabary J, Kavitt RT, Garrett CG, Vaezi MF (2012) Clin Gastroenterol Hepatol 10: 1110-6 Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Slaughter JC, Goutte M, Rymer JA, Oranu AC, Schneider JA, Garrett CG, Hagaman D, Vaezi MF (2011) Clin Gastroenterol Hepatol 9: 868-74 Ambulatory monitoring for gastroesophageal reflux disease: where do we stand? Vaezi MF (2015) Clin Gastroenterol Hepatol 13: 892-4 APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts. Hong J, Chen Z, Peng D, Zaika A, Revetta F, Washington MK, Belkhiri A, El-Rifai W (2016) Oncotarget 7: 16688-702 p73 protein regulates DNA damage repair. Zaika E, Wei J, Yin D, Andl C, Moll U, El-Rifai W, Zaika AI (2011) FASEB J 25: 4406-14 Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts. Bhardwaj V, Horvat A, Korolkova O, Washington MK, El-Rifai W, Dikalov SI, Zaika AI (2016) Carcinogenesis 37: 1161-1169 Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Hom C, Vaezi MF (2013) Drugs 73: 1281-95 Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole. Morgan D, Pandolfino J, Katz PO, Goldstein JL, Barker PN, Illueca M (2010) Aliment Pharmacol Ther 32: 200-8 Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study. Shaheen NJ, Crockett SD, Bright SD, Madanick RD, Buckmire R, Couch M, Dellon ES, Galanko JA, Sharpless G, Morgan DR, Spacek MB, Heidt-Davis P, Henke D (2011) Aliment Pharmacol Ther 33: 225-34 Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Vaezi MF, Slaughter JC, Smith BS, Washington MK, Jerome WG, Garrett CG, Hagaman D, Goutte M (2010) Aliment Pharmacol Ther 32: 916-24 Use of healthcare resources among medically and surgically treated patients with gastroesophageal reflux disease: a population-based study. Holzman MD, Mitchel EF, Ray WA, Smalley WE (2001) J Am Coll Surg 192: 17-24 Idiopathic (primary) achalasia: a review. Patel DA, Kim HP, Zifodya JS, Vaezi MF (2015) Orphanet J Rare Dis 10: 89 Health care utilization after medical and surgical therapy for gastroesophageal reflux disease: a population-based study, 1996 to 2000. Khaitan L, Ray WA, Holzman MD, Smalley WE (2003) Arch Surg 138: 1356-61 Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors. Zaika E, Bhardwaj V, Wei J, Washington MK, Souza R, El-Rifai W, Zaika A (2013) PLoS One 8: e64306 Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Varanasi RV, Fantry GT, Wilson KT (1998) Helicobacter 3: 188-94 Therapeutic strategies for laryngeal manifestations of gastroesophageal reflux disease. Yuksel ES, Vaezi MF (2013) J Clin Gastroenterol 47: 195-204 Approach to the patient with presumed extraoesophageal GERD. Ates F, Vaezi MF (2013) Best Pract Res Clin Gastroenterol 27: 415-31 Extraesophageal manifestations of gastroesophageal reflux disease. Hom C, Vaezi MF (2013) Gastroenterol Clin North Am 42: 71-91 An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis. Yuksel ES, Slaughter JC, Mukhtar N, Ochieng M, Sun G, Goutte M, Muddana S, Gaelyn Garrett C, Vaezi MF (2013) Neurogastroenterol Motil 25: e315-23 Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. Navarro Silvera SA, Mayne ST, Risch HA, Gammon MD, Vaughan T, Chow WH, Dubin JA, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ (2011) Ann Epidemiol 21: 543-50 Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis. Navarro Silvera SA, Mayne ST, Gammon MD, Vaughan TL, Chow WH, Dubin JA, Dubrow R, Stanford JL, West AB, Rotterdam H, Blot WJ, Risch HA (2014) Ann Epidemiol 24: 50-7 Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. Gutschow CA, Collet P, Prenzel K, Hölscher AH, Schneider PM (2005) J Gastrointest Surg 9: 941-8 Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy. Shaheen NJ, Madanick RD, Alattar M, Morgan DR, Davis PH, Galanko JA, Spacek MB, Vaughn BV (2008) Dig Dis Sci 53: 1493-9 Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay. Naik RD, Vaezi MF (2015) Expert Rev Gastroenterol Hepatol 9: 969-82 Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Saritas Yuksel E, Hong SK, Strugala V, Slaughter JC, Goutte M, Garrett CG, Dettmar PW, Vaezi MF (2012) Laryngoscope 122: 1312-6 Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Francis DO, Goutte M, Slaughter JC, Garrett CG, Hagaman D, Holzman MD, Vaezi MF (2011) Laryngoscope 121: 1902-9 Significance and degree of reflux in patients with primary extraesophageal symptoms. Fletcher KC, Goutte M, Slaughter JC, Garrett CG, Vaezi MF (2011) Laryngoscope 121: 2561-5 The role of impedance monitoring in patients with extraesophageal symptoms. Kavitt RT, Yuksel ES, Slaughter JC, Garrett CG, Hagaman D, Higginbotham T, Vaezi MF (2013) Laryngoscope 123: 2463-8 The Pathogenesis and Management of Achalasia: Current Status and Future Directions. Ates F, Vaezi MF (2015) Gut Liver 9: 449-63
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.